44 related articles for article (PubMed ID: 12690374)
1. Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic.
Eldib AA; Patil P; Nischal KK; Mitchell ER; Hiasat JG; Pihlblad MS
J AAPOS; 2021 Dec; 25(6):336.e1-336.e4. PubMed ID: 34737082
[TBL] [Abstract][Full Text] [Related]
2. Prolonged central nervous system and respiratory depression in preterm neonates after exposure to brimonidine tartrate and timolol maleate ophthalmic drops.
Azarcon CP; Santiago DE
GMS Ophthalmol Cases; 2020; 10():Doc25. PubMed ID: 32676270
[No Abstract] [Full Text] [Related]
3. Respiratuvar depression after accidental nasal ingestion of brimonidine eye drops in infant.
Gunes A; Balik H; Yel S; Kocamaz H; Bosnak M
Turk J Emerg Med; 2016 Dec; 16(4):169-170. PubMed ID: 27995209
[TBL] [Abstract][Full Text] [Related]
4. Rare Diseases Leading to Childhood Glaucoma: Epidemiology, Pathophysiogenesis, and Management.
Abdolrahimzadeh S; Fameli V; Mollo R; Contestabile MT; Perdicchi A; Recupero SM
Biomed Res Int; 2015; 2015():781294. PubMed ID: 26451378
[TBL] [Abstract][Full Text] [Related]
5. In vivo assessment of aqueous humor dynamics upon chronic ocular hypertension and hypotensive drug treatment using gadolinium-enhanced MRI.
Ho LC; Conner IP; Do CW; Kim SG; Wu EX; Wollstein G; Schuman JS; Chan KC
Invest Ophthalmol Vis Sci; 2014 Apr; 55(6):3747-57. PubMed ID: 24764067
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic management of glaucoma in childhood.
Moore W; Nischal KK
Paediatr Drugs; 2007; 9(2):71-9. PubMed ID: 17407363
[TBL] [Abstract][Full Text] [Related]
7. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
Razeghinejad MR; Sawchyn AK; Katz LJ
Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
[TBL] [Abstract][Full Text] [Related]
8. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
Greenfield DS; Liebmann JM; Ritch R
J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
[TBL] [Abstract][Full Text] [Related]
9. Is brimonidine ophthalmic a safe therapy for infants?
Daubert GP
J Clin Pharm Ther; 2006 Jun; 31(3):289-92. PubMed ID: 16789995
[TBL] [Abstract][Full Text] [Related]
10. Apparent central nervous system depression in infants after the use of topical brimonidine.
Carlsen JO; Zabriskie NA; Kwon YH; Barbe ME; Scott WE
Am J Ophthalmol; 1999 Aug; 128(2):255-6. PubMed ID: 10458196
[TBL] [Abstract][Full Text] [Related]
11. Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension.
Craven ER; Walters TR; Williams R; Chou C; Cheetham JK; Schiffman R;
J Ocul Pharmacol Ther; 2005 Aug; 21(4):337-48. PubMed ID: 16117698
[TBL] [Abstract][Full Text] [Related]
12. Brimonidine--an alpha 2-agonist for glaucoma.
Med Lett Drugs Ther; 1997 Jun; 39(1002):54-5. PubMed ID: 9198727
[No Abstract] [Full Text] [Related]
13. Safety and efficacy of brimonidine in children with glaucoma.
Enyedi LB; Freedman SF
J AAPOS; 2001 Oct; 5(5):281-4. PubMed ID: 11641636
[TBL] [Abstract][Full Text] [Related]
14. Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers.
Mungan NK; Wilson TW; Nischal KK; Koren G; Levin AV
J AAPOS; 2003 Feb; 7(1):69-70. PubMed ID: 12690374
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]